AAAAAA

   
Results: 1-7 |
Results: 7
EFFECT OF INFLUENZA IMMUNIZATION ON IMMUNOLOGICAL AND VIROLOGICAL CHARACTERISTICS OF PEDIATRIC-PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: JACKSON CR VAVRO CL VALENTINE ME PENNINGTON KN LANIER ER KATZ SL DILIBERTI JH MCKINNEY RE WILFERT CM STCLAIR MH
Citation: Cr. Jackson et al., EFFECT OF INFLUENZA IMMUNIZATION ON IMMUNOLOGICAL AND VIROLOGICAL CHARACTERISTICS OF PEDIATRIC-PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Pediatric infectious disease journal, 16(2), 1997, pp. 200-204
EFFECT OF 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD) ON INFLUENZA-VIRUS HOST-RESISTANCE IN MICE
Authors: BURLESON GR LEBREC H YANG YG IBANES JD PENNINGTON KN BIRNBAUM LS
Citation: Gr. Burleson et al., EFFECT OF 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD) ON INFLUENZA-VIRUS HOST-RESISTANCE IN MICE, Fundamental and applied toxicology, 29(1), 1996, pp. 40-47
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DRUG SUSCEPTIBILITY DURING ZIDOVUDINE (AZT) MONOTHERAPY COMPARED WITH AZT PLUS 2',3'-DIDEOXYINOSINE OR AZT PLUS 2',3'-DIDEOXYCYTIDINE COMBINATION THERAPY
Authors: LARDER BA KOHLI A BLOOR S KEMP SD HARRIGAN PR SCHOOLEY RT LANGE JMA PENNINGTON KN STCLAIR MH
Citation: Ba. Larder et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DRUG SUSCEPTIBILITY DURING ZIDOVUDINE (AZT) MONOTHERAPY COMPARED WITH AZT PLUS 2',3'-DIDEOXYINOSINE OR AZT PLUS 2',3'-DIDEOXYCYTIDINE COMBINATION THERAPY, Journal of virology, 70(9), 1996, pp. 5922-5929
VIROLOGICAL AND IMMUNOLOGICAL BENEFITS OF INITIAL COMBINATION THERAPYWITH ZIDOVUDINE AND ZALCITABINE OR DIDANOSINE COMPARED WITH ZIDOVUDINE MONOTHERAPY
Authors: SCHOOLEY RT RAMIREZRONDA C LANGE JMA COOPER DA LAVELLE J LEFKOWITZ L MOORE M LARDER BA STCLAIR M MULDER JW MCKINNIS R PENNINGTON KN HARRIGAN PR KINGHORN I STEEL H ROONEY JF RAY MG KURITZKES D RIVERAVASQUEZ C SANTANA J VANLEEUWEN R BOUCHER C REISS P VEENSTRA J KEET R PIERCE P HAAS D BARNES B LOEWENTHAL M DARCYEVANS C KEMP S KOHLI A MYERS R YEO J EMERY S ROMERO C ANDREWS J HANSON C SHORTINO D PATTISHALL K BARRY D
Citation: Rt. Schooley et al., VIROLOGICAL AND IMMUNOLOGICAL BENEFITS OF INITIAL COMBINATION THERAPYWITH ZIDOVUDINE AND ZALCITABINE OR DIDANOSINE COMPARED WITH ZIDOVUDINE MONOTHERAPY, The Journal of infectious diseases, 173(6), 1996, pp. 1354-1366
IN-VITRO COMPARISON OF SELECTED TRIPLE-DRUG COMBINATIONS FOR SUPPRESSION OF HIV-1 REPLICATION - THE INTER-COMPANY COLLABORATION PROTOCOL
Authors: STCLAIR MH PENNINGTON KN ROONEY J BARRY DW
Citation: Mh. Stclair et al., IN-VITRO COMPARISON OF SELECTED TRIPLE-DRUG COMBINATIONS FOR SUPPRESSION OF HIV-1 REPLICATION - THE INTER-COMPANY COLLABORATION PROTOCOL, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 83-91
RAPID SCREENING OF ANTIRETROVIRAL COMBINATIONS
Authors: CLAIR MS PENNINGTON KN ROONEY J BARRY DW
Citation: Ms. Clair et al., RAPID SCREENING OF ANTIRETROVIRAL COMBINATIONS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 24-27
A CLINICAL AND MOLECULAR CHARACTERIZATION OF LONG-TERM SURVIVAL IN PEDIATRIC HIV PATIENTS
Authors: VAVRO CL JACKSON CR STCLAIR MH PENNINGTON KN LANIER ER VALENTINE ME MCKINNEY RE
Citation: Cl. Vavro et al., A CLINICAL AND MOLECULAR CHARACTERIZATION OF LONG-TERM SURVIVAL IN PEDIATRIC HIV PATIENTS, Journal of cellular biochemistry, 1995, pp. 245-245
Risultati: 1-7 |